In the golden autumn of October, with gentle breezes and pleasant weather, academic conferences gather in Central Plains. From October 17th to 18th, 2026, the "Fifth Standing Committee Meeting and Ninth Committee Congress of the Second Committee of the Hematology Branch of the Chinese Geriatrics Society" was grandly held in Zhengzhou, Henan Province. This conference was co-organized and hosted by the First Affiliated Hospital of Zhengzhou University, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Henan Cancer Hospital and Henan Provincial People's Hospital. Over a hundred experts, including Professors Chang Junbiao, Huang Xiaojun, Zhang Xiaohui and Li Junmin, gathered together.

The opening ceremony was presided over by Professors Wang Fang and Yan Hua. From the warm welcome of the host organizers to the heartfelt review of the nine-year dedication of the branch by Chairman Li Junmin; From President Zhao Tongjin of Zhengzhou University Henan Medical College's expectations for the innovation of Central Plains medicine to Professor Huang Xiaojun's high-level guidance; Then came the sincere wishes of Professor Zhang Xiaohui, the incoming chairperson of the Hematology Branch of the Chinese Medical Association, and the heartwarming speech by President Song Yongping of the First Affiliated Hospital of Zhengzhou University, the host - each of these remarks was the most powerful boost to the cause of geriatric hematology.

The afterglow of the speech still lingers, but the collision of ideas is about to begin. Next, we officially move on to the academic session - the first "Keynote Forum" will be hosted by Professors Liu Qifa and Hou Ming. Professor Chang Junbiao was the first to deliver a report titled "Research and Development of New Nucleoside Drugs Oriented towards Meeting Clinical Needs". Experts such as Liu Delong and Wang Weiqing held discussions on "The future direction of cell therapy" and "Metabolism and Aging". Endocrinology experts interpreted aging and clonal evolution from a metabolic perspective, which aroused strong interest and in-depth discussions among the attending experts. A stone from another mountain can polish jade. The exchange among different disciplines has also brought new inspiration and perspectives to the research of geriatric hematology. Subsequently, Chairperson Li Junmin delved deeply into "From the cure of APL to the long-term management of AML", Professor Song Yongping sparked heated discussions on "The treatment trends of chronic myeloid Leukemia in the TKI era", and Professor Zhou Keshu shared "The latest research Progress of CLL". The agenda took into account the tracking of new technologies such as CAR-T and clinical norms, and conducted in-depth discussions on the basic and clinical transformation. Chairman Li Junmin made a summary of the conference: This meeting not only promoted the mature management model, but also improved the diagnosis and treatment level of elderly blood diseases in our country, contributing strong professional strength to the implementation of the healthy aging strategy.

Special session on platelet diseases

On the afternoon of October 17th, a special meeting on platelet diseases was held offline in Zhengzhou. Professor Zhang Xiaohui shared the research on data-driven outcome prediction and treatment of pregnancy complicated with difficult blood diseases, which sparked a lively discussion among the experts present. Professor Cheng Yunfeng shared a special report on the differentiation of thrombocytopenia. Professor Zhou Hu shared a special report on TCP-related bleeding management strategies. Professor Yang Mo shared the role of 5-HT in the generation of TPO. Professor Shi Yan introduced the therapeutic potential of orelubrutinib in ITP. Finally, Professor Hou Ming gave a detailed introduction to the "Updated 2025 Edition of the Latest Adult ITP Guidelines". The conference content covered basic research, scientific research, and the construction of big data queues. The experts attending the conference, based on the research data of their own teams and clinical practice experience, deeply interpreted the new discoveries, new concepts, and clinical difficulties to be solved in the field. The content was both cutting-edge and practical. Finally, Chairperson Hou Ming made a summary of the conference, and the meeting came to a successful conclusion.

Red Blood Cell Special Session

On the afternoon of October 17th, the "Red Blood Cell Disease Special Session" came to a successful conclusion in Zhongyue Hall. The meeting was chaired by Professors Zhang Fengkui and Yan Hua. Experts such as Han Bing, Fu Rong, Sun Zimin, Song Qiang, Zhang Fengkui and Zhao Xin delivered wonderful special reports on the new progress in the treatment of PNH and AIHA, umbilical cord blood transplantation, differential diagnosis of AA and immunosuppressive therapy for severe/non-severe AA. The conference adopted a "report + in-depth commentary" format, closely integrating cutting-edge progress with clinical practice. This conference pointed out the direction for the standardized and individualized diagnosis and treatment of red blood cell diseases and achieved a complete success.

MDS Special Session

The "MDS Special Session" was held on the afternoon of October 17th. The special session was chaired by Professor Chang Chunkang from Shanghai Sixth People's Hospital and invited top experts in the field of MDS across the country to give lectures and exchange ideas. After the speech by Chairman Chang Chunkang, the meeting was first addressed by Professor Xiao Zhijian from the Blood Disease Hospital of the Chinese Academy of Medical Sciences, who explained the current situation and problems of immunotherapy for MDS. Professor Ge Zheng from Zhongda Hospital Affiliated to Southeast University introduced the clonal evolution of MDS from a clinical perspective. Professor Li Bing from the Blood Disease Hospital, Chinese Academy of Medical Sciences, delivered a lecture on the progress of MPN treatment. Professor Zhao Youshan from Shanghai Sixth People's Hospital analyzes the treatment challenges of high-risk MDS. At the end of the meeting, Professor Hu Xiaoxia from Ruijin Hospital expounded on the problems and challenges faced in the transplantation treatment of MDS. This special session focused on the cutting-edge of diagnosis and treatment of MDS and related blood diseases, conducting in-depth discussions on clinical difficulties, treatment strategies and research directions, and providing a high-level academic exchange platform for the participants. The on-site discussion atmosphere was lively. The cutting-edge concepts and practical experiences shared by the experts are conducive to promoting the improvement of the standardized diagnosis and treatment level of MDS in China. The special session successfully completed all its agendas. The experts attending the meeting unanimously expressed that in the future, they will continue to strengthen multi-center collaboration and clinical translational research, work together to overcome the difficulties in the diagnosis and treatment of MDS, and benefit more patients with blood diseases.

Cellular immunity Special Session

The "Cell Immunotherapy Special Session" was held on the afternoon of October 17th. The meeting was presided over by Yuan Hailong, and Song Yongping, Li Junmin and Jiang Ming delivered opening remarks.

During the academic session, Li Yuhua, Zhou Hongsheng and Lin Quande respectively shared their insights on the CAR-T joint strategy, development history and the cutting-edge progress of IMS in 2026. Bai Ou and Wang Xiujue focused on the clinical practice and cases of relapsed/refractory large B-cell lymphoma and multiple myeloma. Many experts participated in the discussion and comments. Song Yongping, Fang Baijun, Ping Baohong, Zhu Zunmin, Zhou Keshu and others presided over each session. Finally, Professor Jiang Ming made a summary of the meeting. This special session showcased the latest achievements in cellular immunotherapy, providing new ideas for the diagnosis and treatment of hematological malignancies and promoting the high-quality development of the discipline.

Comprehensive assessment and supportive treatment special session

The "Comprehensive Assessment and Supportive Treatment Special Session" was grandly held on the afternoon of October 17th. At the beginning of the conference, Li Junmin, the chairperson of the Hematology Branch of the Chinese Geriatrics Society, and Professor Zhu Hongli, the vice chairperson of the Hematology Branch of the Chinese Geriatrics Society, delivered opening remarks. Chairperson Li Junmin affirmed the significance of comprehensive geriatric assessment and emphasized the need for dynamic assessment of elderly patients with hematological malignancies. At the same time, he proposed the application prospects and demands of artificial intelligence in the assessment field in the future. Professors Zhang Yikun, Liu Peng, Lu Xuechun, Feng Ru and Li Rong respectively shared their insights on hot topics in elderly hematological diseases from the perspectives of nutritional management for elderly hematological malignancies, elderly diffuse large B-cell lymphoma, the application of logomics in individualized and precise treatment of hematological diseases, and exploration of comprehensive assessment and precise treatment for elderly acute myeloid leukemia. Several experts in the field of geriatric hematology engaged in in-depth discussions on the above issues. At the end of the meeting, Professors Zhu Hongli and Xu Bing made special summaries. This conference focused on in-depth discussions on clinical difficult issues such as comprehensive assessment and management of hematological malignancies in the elderly, providing new ideas for the development of precise diagnosis and treatment of hematological diseases in the elderly.

Nursing TNT Special session

The two-day academic conference on nursing TNT came to a successful conclusion. This special session takes clinical nutrition care as its main thread, while also covering the nursing characteristics of multiple specialties such as geriatrics, hematology, oncology, and critical care. It builds an academic exchange platform integrating theoretical lectures, guideline interpretation, practical operation norms, and case discussions, gathering nursing colleagues to jointly explore the difficulties in nutrition care. On the 17th, domestic nutrition doctors and nursing experts at the venue systematically gave lectures on an overview of clinical nutrition, nutrition screening and assessment diagnosis, as well as the basic principles of nutrition treatment. The practical experience of ONS as the cornerstone of nutritional support for patients with hematological malignancies, the Dietary Guidelines for adult patients with hematological malignancies, focuses on the nutritional risk issues of the elderly tumor population. The guests also held special discussions on the hot and difficult issues in clinical nutrition. Subsequently, we will explain the functions of human nutrients and enteral nutrition preparations to consolidate the theoretical foundation of nutritional support for the elderly and critically ill patients.

The special session on the 18th will cover water and electrolyte balance and imbalance, oral nutritional supplementation, and patient compliance management, focusing on common problems that are prone to occur among the elderly, such as electrolyte imbalance, poor eating, and insufficient medication compliance. This paper introduces the implementation of enteral nutrition standards, pipeline management, and provides prevention and control strategies for complications and risks related to enteral nutrition. Through typical case discussions on enteral nutrition care for elderly patients with severe EN water-sodium imbalance and multiple traumas, the complexity of nutritional support and key points of individualized care for the elderly are deeply analyzed. This special session covers the entire process of nutritional risk screening, oral nutritional supplementation, enteral nutrition management, complication prevention and control, as well as real case discussions. It integrates the characteristics of hematology, oncology, and geriatrics. The content is closely related to real clinical scenarios, helping the participating nursing staff systematically build a knowledge system for patient nutritional care, which is beneficial for optimizing the nutritional management of elderly, oncology, and critically ill patients. Improving the ability of specialized nursing has significant practical guiding significance.

Exchange on standardized diagnosis and treatment of multiple myeloma

On the afternoon of October 17, 2026, the "Special Academic Exchange Conference on Standardized Diagnosis and Treatment of Myeloma" concluded successfully in Zhengzhou. This conference, with the strong support of the Hematology Branch, was led and coordinated by Director Fang Baijun, Director Yan Hua and Director Wang Fang. It brought together many renowned hematology experts in the province to conduct in-depth exchanges and discussions on the standardized diagnosis and treatment of multiple myeloma (MM). Myeloma is a common blood disease among the elderly. The conference content closely follows the cutting-edge of myeloma diagnosis and treatment and proposes treatment plans that are in line with the actual situation in Henan. In addition, the meeting also started from the advantages of the drug mechanism and combined with evidence-based evidence to deeply explain the clinical value of the second-generation proteasome inhibitors in the treatment of MM. The conference was rich in content and the academic atmosphere on site was strong, fully demonstrating the powerful cohesion and academic influence of the branch. This meeting has significant guiding significance for promoting the standardized diagnosis and treatment of blood diseases among the elderly in our country. In the future, the experts attending the conference will continue to work together with one heart to promote the high-quality development of hematology in our country.

The Lymphoma Special session will be held from 13:30 to 17:50. Experts such as Li Junmin and Song Yongping delivered opening remarks. This session features eight topics, focusing on the cutting-edge and clinical aspects of lymphoma. Professors Yi Hongmei and Jing Hongmei discussed the pathological diagnosis and treatment of marginal zone lymphoma. Professor Bai Ou shared the research on HBV-positive DLBCL. Professor Huang Liang expounded on CAR-T cell therapy; Professor Zhao Ailin reported on the transformation research of hemophagocytic syndrome. Professor Xu Wei shared the first-line treatment of DLBCL molecular typing. Professor Su Liping explores allogeneic transplantation for peripheral T-cell lymphoma. Professor Zhao Donglu interprets the key points of the CSCO Lymphoma Guidelines (2026) update. The conference brought together authoritative experts from Ruijin Hospital, the First Affiliated Hospital of Zhengzhou University, Peking University Third Hospital, West China Hospital and other institutions, covering pathology, immunology, targeted therapy and transplantation. The academic atmosphere was strong, effectively promoting disciplinary exchanges and standardized diagnosis and treatment.

Myeloma Special Session

The "Multiple Myeloma Special Session" concluded successfully in Zhengzhou. This special lecture is distinctive and highly practical: authoritative experts deeply interpret the key points of the update of the 2026 version of the MM guidelines, and systematically sort out the standardized treatment strategies for elderly frail MM and newly diagnosed NDMM. Focus on the clinical transformation of cutting-edge cell therapy and share real case practices from international medical platforms; At the same time, it gathers the construction experience and typical cases of plasma cell diagnosis and treatment platforms from multiple hospitals within the province, and connects the top-level norms with the clinical implementation path. The in-depth and thorough discussion throughout the event injected strong impetus into the high-quality development of the myeloma discipline in Henan Province.

Leukemia Special Session

On the afternoon of October 18, 2026, the academic exchange meeting on "Leukemia Special Session" concluded successfully in Zhengzhou. This conference, with the strong support of the Hematology Branch, was led and coordinated by Chairperson Li Junmin and Vice Chairperson Xu Bing, gathering nearly 30 renowned hematology experts from across the country.

The conference closely focused on the cutting-edge of hematological tumor diagnosis and treatment in the context of an aging population, deeply concentrating on research hotspots such as the diagnosis and treatment of elderly AML, CML drug withdrawal (TFR), and new MRD detection technologies, and carried out in-depth exchanges and discussions. The on-site academic atmosphere was intense, fully demonstrating the strong cohesion and academic influence of the branch. This meeting has significant guiding significance for promoting the standardized diagnosis and treatment of blood diseases among the elderly in our country. In the future, the experts attending the conference will continue to work together with one heart to promote the high-quality development of hematology in our country.

Transplantation and Infection Special Session

The "Transplantation and Infection Special Session" was chaired by Professor Liu Qifa, the vice chairperson of the Hematology Branch of the Chinese Geriatrics Society. This academic conference focuses on the cutting-edge hot topics in the field of transplantation and infection: Professor Feng Sizhou from the Hospital of Hematology, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences) elaborates on the clinical strategies of empirical anti-infection treatment for granulocytosis with fever in the era of high incidence of CRO infection, based on the consensus of Chinese experts and a large amount of clinical work data. Professor Wang Yu from Peking University People's Hospital provided an in-depth elaboration on transplantation for elderly leukemia patients based on extensive research from his own center and a large number of studies both at home and abroad. Professor Yang Ting from the First Affiliated Hospital of Fujian Medical University delved deeply into the construction and significance of HCU, starting from the treatment of critically ill patients with blood disorders. Professor Zhou Hu from Henan Cancer Hospital shared the progress in the diagnosis and treatment of myelofibrosis and his personal experience. Professor Hong Mei from Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, elaborated in detail on the progress in the diagnosis and treatment of severe infections in hematological diseases. Professor Hu Jiong from Ruijin Hospital Affiliated to Shanghai Jiao Tong University systematically expounded on the improvement and prospects of the GVHD prevention system based on clinical research. The discussion guests and expert speakers engaged in a lively discussion on the above topics. The theme of this conference highlights practicality and has strong practical value for clinical work, especially in the diagnosis and treatment of transplantation and infection as well as overall management strategies.

Experimental Diagnosis Special session

The "Experimental Diagnosis Special Session" was held in Huayu Hall, Zhengzhou on October 18th. Li Junmin and Liu Lin delivered the opening remarks.

This session focuses on the experimental diagnosis and clinical progress of blood diseases. Wang Sanbin, Xu Xi, Sun Qi and other experts successively discussed hot topics such as the VACAG regimen in the treatment of newly diagnosed fit AML, the immune microenvironment of elderly AML, precise diagnosis of large B-cell lymphoma, drug resistance and microenvironment of MDS and its transformation to AML, and the pathogenesis of t(6;9) AML. Mi Ruihua shared her experience in the treatment of refractory and relapsed acute myeloid leukemia. Each report is accompanied by expert comments, creating a strong academic atmosphere. Liu Lin made the chairperson's summary. The special session covered the cutting-edge diagnosis of AML, MDS and lymphoma, gathering many authoritative experts. It effectively promoted the integration of hematological experimental diagnosis and clinical practice, and facilitated the standardized development of the discipline.

Special session for Young scholars

The "Young Scholars Special Session" was held in the Jinxiu Hall on the afternoon of October 18th. The special session was opened and hosted by Professor Bai Ou, with Chairperson Li Junmin and President Song Yongping delivering the opening remarks. Many young experts gave reports on the cutting-edge topics in the field of hematology, covering hematopoietic stem cell transplantation, the immune mechanism of EBV-positive diffuse large B-cell lymphoma, bleeding and coagulation research, immunotherapy for multiple myeloma, diagnosis and treatment of HLH, immunosuppression of recurrence after transplantation, and the progression of peripheral T-cell lymphoma. After each report, a special discussion was set up. All the lecturers shared their knowledge generously, the hosts made smooth transitions, and the discussion experts engaged in lively exchanges. Everyone felt that they had gained a lot. This conference once again provided a platform for young hematologists to exchange ideas, promote collaboration and came to a successful conclusion.

Special session for network collaboration units

This conference of the network collaboration units was based on clinical practice, focused on innovative development, and centered on the achievements of the network collaboration units' characteristic practical activities within the collaboration network, such as discussions on difficult cases, sharing of classic case experiences, and practical results of integrated traditional Chinese and Western medicine diagnosis and treatment. The experts imparted their knowledge generously and explained in a simple and understandable way, bringing us a series of high-quality and high-level academic reports. The on-site discussion atmosphere was intense and the communication was thorough, effectively promoting academic exchanges and intellectual collisions in this field. The participants expressed that they would fully absorb the achievements of the conference, focus on clinical practice, adhere to innovation while maintaining the right path, continuously enhance their capabilities in diagnosis and treatment as well as scientific research, better serve patients, and promote the high-quality development of the collaborative network.

Standing Committee: Unite our efforts, shoulder our mission, forge ahead with determination, and write a new chapter

On October 17, 2026, the fifth Standing Committee Meeting of the Second Committee of the Hematology Branch of the Chinese Geriatrics Society was held in Zhengzhou. Vice Secretary-General Zhao Jicheng of the Chinese Society of Geriatrics attended the Standing Committee meeting as an observer and conveyed the latest meeting spirit of the General Association to the Standing Committee. He encouraged the Hematology Branch to unite and strive forward under the leadership of Chairperson Li Junmin, adhere to the correct path and innovate, and write a new chapter for the cause of geriatrics in China. The meeting heard and deliberated on the 2025 annual work report of Chairperson Li Junmin, and approved the list of 15 additional standing committee members and 27 additional committee members for this term. The meeting simultaneously arranged the seven key tasks for the next step, focusing on continuous efforts in the integration of Party building, academic training, multi-center clinical research, and the construction of specialized diagnosis and treatment standards for the elderly. It also planned the relevant arrangements for the 10th Committee Congress of the branch, aiming to build consensus and determine the direction for the high-quality development of geriatric hematology.

Meeting Summary: Adhere to the right path and innovate, jointly building the peak of hematology

After nine years of hard work, the Central Plains has embarked on a new journey. The fifth Standing Committee Meeting and the Ninth Committee Meeting of the Second Committee of the Hematology Branch of the Chinese Geriatrics Society came to a successful conclusion! More than 400 experts gathered in Zhengzhou, led by a keynote forum, which included over ten specialized sessions on platelets, red blood cells, MDS, cellular immunity, multiple myeloma, lymphoma, leukemia, etc., to jointly explore the cutting-edge and standardized aspects of geriatric blood diseases. The Standing Committee has outlined seven key points to replenish new forces and carry forward the original aspiration and mission. From basic transformation to clinical practice, from comprehensive assessment to nutritional care, the branch has continuously gathered the wisdom of the whole country to implement the strategy of healthy aging. Looking ahead, the branch will continue to forge ahead with vigor, adhere to principles while innovating, and with a broader perspective and a more vigorous attitude, jointly build the peak of hematology and safeguard the light of life!